Evaluation of tumor M2-pyruvate kinase (Tumor M2-PK) as a biomarker for pancreatic cancer

被引:0
作者
Indika A. Bandara
Minas Baltatzis
Sudip Sanyal
Ajith K. Siriwardena
机构
[1] Manchester Royal Infirmary,Regional Hepato
[2] University of Manchester,Pancreato
来源
World Journal of Surgical Oncology | / 16卷
关键词
Pancreatic cancer; Cancer prognosis; Tumor M2-PK;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
[31]   The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis [J].
Hu, Wei-Min ;
Liu, Si-Qing ;
Zhu, Kong-Fan ;
Li, Wei ;
Yang, Zhi-Jian ;
Yang, Qiang ;
Zhu, Zhong-Chao ;
Chang, Jian .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
[32]   Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer [J].
Anderson, Marybeth ;
Marayati, Raoud ;
Moffitt, Richard ;
Yeh, Jen Jen .
ONCOTARGET, 2017, 8 (34) :56081-56094
[33]   Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer [J].
Chien, Wenwen ;
Sun, Qiao-Yang ;
Lee, Kian Leong ;
Ding, Ling-Wen ;
Wuensche, Peer ;
Torres-Fernandez, Lucia A. ;
Tan, Siew Zhuan ;
Tokatly, Itay ;
Zaiden, Norazean ;
Poellinger, Lorenz ;
Mori, Seiichi ;
Yang, Henry ;
Tyner, Jeffrey W. ;
Koeffler, H. Philip .
MOLECULAR ONCOLOGY, 2015, 9 (04) :889-905
[34]   Pyruvate kinase M2 and its evolving role as a prognostic marker in systemic malignancies besides colorectal carcinomas [J].
Kapoor, Shailendra .
TUMOR BIOLOGY, 2013, 34 (01) :611-611
[35]   Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer [J].
Su, Yun ;
Loos, Martin ;
Giese, Natalia ;
Metzen, Eric ;
Buechler, Markus W. ;
Friess, Helmut ;
Kornberg, Arno ;
Buechler, Peter .
CANCER, 2012, 118 (04) :960-972
[36]   TYROBP promotes the spread of pancreatic cancer by causing M2 TAM polarization [J].
Zhong, Dingwen ;
Liao, Yonghui ;
Chen, Wenhui ;
Huang, Xianyu ;
Liu, Jiaxin ;
Wang, Zheng .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (12) :2926-2939
[37]   Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: A quid pro quo in pancreatic cancer [J].
Partecke, L. I. ;
Guenther, C. ;
Hagemann, S. ;
Jacobi, C. ;
Merkel, M. ;
Sendler, M. ;
van Rooijen, N. ;
Kaeding, A. ;
Trung, D. Nguyen ;
Lorenz, E. ;
Diedrich, S. ;
Weiss, F. U. ;
Heidecke, C. D. ;
von Bernstorff, W. .
PANCREATOLOGY, 2013, 13 (05) :508-516
[38]   CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment [J].
Tao, Jinxin ;
Gu, Yani ;
Zhang, Zeyu ;
Weng, Guihu ;
Liu, Yueze ;
Ren, Jie ;
Qiu, Jiangdong ;
Shi, Yanan ;
Wang, Yuanyang ;
Su, Dan ;
Wang, Ruobing ;
Fu, Yifan ;
Liu, Tao ;
Ye, Liyuan ;
Luo, Wenhao ;
Chen, Hao ;
Yang, Gang ;
Cao, Zhe ;
Huang, Hua ;
Xiao, Jianchun ;
Ren, Bo ;
You, Lei ;
Zhang, Taiping ;
Zhao, Yupei .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
[39]   mir-329 restricts tumor growth by targeting grb2 in pancreatic cancer [J].
Wang, Xinjing ;
Lu, Xiongxiong ;
Zhang, Tian ;
Wen, Chenlei ;
Shi, Minmin ;
Tang, Xiaomei ;
Chen, Hao ;
Peng, Chenghong ;
Li, Hongwei ;
Fang, Yuan ;
Deng, Xiaxing ;
Shen, Baiyong .
ONCOTARGET, 2016, 7 (16) :21441-21453
[40]   FTS and 2-DG induce pancreatic cancer cell death and tumor shrinkage in mice [J].
Goldberg, L. ;
Israeli, R. ;
Kloog, Y. .
CELL DEATH & DISEASE, 2012, 3 :e284-e284